Dr Ing Financials
| DRPRY Stock | 6.45 0.14 2.22% |
DRPRY |
Understanding current and past Dr Ing Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Dr Ing's financial statements are interrelated, with each one affecting the others. For example, an increase in Dr Ing's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Dr Ing's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Dr Ing hc. Check Dr Ing's Beneish M Score to see the likelihood of Dr Ing's management manipulating its earnings.
| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | Porscheplatz 1, Stuttgart, |
| Benchmark | Dow Jones Industrial |
| Website | www.porsche.com/international |
| Phone | 49 711 911 0 |
DRPRY Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Dr Ing's current stock value. Our valuation model uses many indicators to compare Dr Ing value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Dr Ing competition to find correlations between indicators driving Dr Ing's intrinsic value. More Info.Dr Ing hc is one of the top stocks in profit margin category among its peers. It also is one of the top stocks in operating margin category among its peers reporting about 1.45 of Operating Margin per Profit Margin. Comparative valuation analysis is a catch-all model that can be used if you cannot value Dr Ing by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dr Ing's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Dr Ing hc Systematic Risk
Dr Ing's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Dr Ing volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Dr Ing hc correlated with the market. If Beta is less than 0 Dr Ing generally moves in the opposite direction as compared to the market. If Dr Ing Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Dr Ing hc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Dr Ing is generally in the same direction as the market. If Beta > 1 Dr Ing moves generally in the same direction as, but more than the movement of the benchmark.
Dr Ing January 30, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Dr Ing help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Dr Ing hc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Dr Ing hc based on widely used predictive technical indicators. In general, we focus on analyzing DRPRY Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Dr Ing's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 9.92 | |||
| Value At Risk | (2.92) | |||
| Potential Upside | 3.53 |
Additional Tools for DRPRY Pink Sheet Analysis
When running Dr Ing's price analysis, check to measure Dr Ing's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Ing is operating at the current time. Most of Dr Ing's value examination focuses on studying past and present price action to predict the probability of Dr Ing's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Ing's price. Additionally, you may evaluate how the addition of Dr Ing to your portfolios can decrease your overall portfolio volatility.